Safety of vaccination against influenza A (H1N1) during pregnancy in the Netherlands: Results on pregnancy outcomes and infant's health: Cross-sectional linkage study

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 123, Issue 5, 2016, Pages 709-717

  Van Der Maas, N ^a   Dijs Elsinga, J ^b   Kemmeren, J ^a   Van Lier, A ^a   Knol, M ^a   De Melker, H ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b Netherlands Perinatal Registry   (Netherlands)

Author keywords

Infant; influenza; pregnancy; safety; vaccination

Indexed keywords

INFLUENZA VACCINE;

ADULT; ARTICLE; CHILD HEALTH; CROSS-SECTIONAL STUDY; DRUG EFFECT; DRUG SAFETY; FEMALE; HEAD CIRCUMFERENCE; HUMAN; INFECTION PREVENTION; INFLUENZA A (H1N1); INFLUENZA VACCINATION; NETHERLANDS; PERINATAL DEATH; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; RESUSCITATION; SMALL FOR DATE INFANT; THIRD TRIMESTER PREGNANCY; HEALTH SURVEY; INFANT; INFLUENZA; INFLUENZA A VIRUS (H1N1); INFORMATION RETRIEVAL; MULTIVARIATE ANALYSIS; NEWBORN; PREGNANCY; PREGNANCY COMPLICATION; STATISTICAL MODEL; TREATMENT OUTCOME;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SURVEYS; HUMANS; INFANT; INFANT HEALTH; INFANT, NEWBORN; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; INFORMATION STORAGE AND RETRIEVAL; LINEAR MODELS; LOGISTIC MODELS; MULTIVARIATE ANALYSIS; NETHERLANDS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; TREATMENT OUTCOME;

EID: 84924066993     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/1471-0528.13329     Document Type: Article

References (39)

1. Rasmussen SA, Jamieson DJ, Bresee JS,. Pandemic influenza and pregnant women. Emerg Infect Dis 2008; 14: 95-100.
2. Skowronski DM, De Serres G,. Is routine influenza immunization warranted in early pregnancy? Vaccine 2009; 27: 4754-70.
3. Mak TK, Mangtani P, Leese J, Watson JM, Pfeifer D,. Influenza vaccination in pregnancy: current evidence and selected national policies. Lancet Infect Dis 2008; 8: 44-52.
4. Kelly H, Mercer G, Cheng A,. Quantifying the risk of pandemic influenza in pregnancy and indigenous people in Australia in 2009. Euro Surveill 2009; 14.
5. Jamieson DJ, Honein MA, Rasmussen SA, Williams JL, Swerdlow DL, Biggerstaff MS, et al., H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 2009; 374: 451-8.
6. Siston AM, Rasmussen SA, Honein MA, Fry AM, Seib K, Callaghan WM, et al., Pandemic 2009 influenza A (H1N1) virus illness among pregnant women in the United States. J Am Med Assoc 2010; 303: 1517-25.
7. Health Council of the Netherlands. Advice vaccination against pandemic influenza A (H1N1) 2009: target groups and priotizing. den Haag: Health Council of the Netherlands, 2009 2009/16.
8. Heinonen OP, Shapiro S, Monson RR, Hartz SC, Rosenberg L, Slone D,. Immunization during pregnancy against poliomyelitis and influenza in relation to childhood malignancy. Int J Epidemiol 1973; 2: 229-35.
9. Heinonen OP, Slone D, Shapiro S,. immunizing agents. In:, Kaufman DW, editor. Birth Defects and Drugs in Pregnancy. Littleton: Publishing Sciences Group; 1977. pp 314-21.
10. Munoz FM, Greisinger AJ, Wehmanen OA, Mouzoon ME, Hoyle JC, Smith FA, et al., Safety of influenza vaccination during pregnancy. Am J Obstet Gynecol 2005; 192: 1098-106.
11. IoM. Immunisation Safety Review: Thiomersal-Containing Vaccines and Neurodevelopmental Disorders. Washington, DC: Institute of Medicine, 2001.
12. Huang WT, Chen WC, Teng HJ, Huang WI, Huang YW, Hsu CW, et al., Adverse events following pandemic A (H1N1) 2009 monovalent vaccines in pregnant women-Taiwan, November 2009-August 2010. PLoS ONE 2011; 6: e23049.
13. Pasternak B, Svanstrom H, Molgaard-Nielsen D, Krause TG, Emborg HD, Melbye M, et al., Vaccination against pandemic A/H1N1 2009 influenza in pregnancy and risk of fetal death: cohort study in Denmark. BMJ 2012; 344: e2794.
14. Pasternak B, Svanstrom H, Molgaard-Nielsen D, Krause TG, Emborg HD, Melbye M, et al., Risk of adverse fetal outcomes following administration of a pandemic influenza A (H1N1) vaccine during pregnancy. J Am Med Assoc 2012; 308: 165-74.
15. Ludvigsson JF, Zugna D, Cnattingius S, Richiardi L, Ekbom A, Ortqvist A, et al., Influenza H1N1 vaccination and adverse pregnancy outcome. Eur J Epidemiol 2013; 28: 579-88.
16. Rubinstein F, Micone P, Bonotti A, Wainer V, Schwarcz A, Augustovski F, et al., Influenza A/H1N1 MF59 adjuvanted vaccine in pregnant women and adverse perinatal outcomes: multicentre study. BMJ 2013; 346: f393.
17. Sammon CJ, Snowball J, McGrogan A, de Vries CS,. Evaluating the hazard of foetal death following H1N1 influenza vaccination; a population based cohort study in the UK GPRD. PLoS ONE 2012; 7: e51734.
18. Haberg SE, Trogstad L, Gunnes N, Wilcox AJ, Gjessing HK, Samuelsen SO, et al., Risk of fetal death after pandemic influenza virus infection or vaccination. N Engl J Med 2013; 368: 333-40.
19. Heikkinen T, Young J, van Beek E, Franke H, Verstraeten T, Weil JG, et al., Safety of MF59-adjuvanted A/H1N1 influenza vaccine in pregnancy: a comparative cohort study. Am J Obstet Gynecol 2012; 207: 177.e1-8.
20. van Lier A, Steens A, Ferreira JA, van der Maas NA, de Melker HE,. Acceptance of vaccination during pregnancy: experience with 2009 influenza A (H1N1) in the Netherlands. Vaccine 2012; 30: 2892-9.
21. PRN-foundation. [ www.perinatreg.nl ] Accessed 18 December 2013.
22. TNO. [ www.tno.nl/downloads/20100608%20Factsheet%20Resultaten%20Vijfde%20Landelijke%20Groeistudie1.pdf ] Accessed 18 December 2013.
23. Verbrugge HP,. Youth health care in The Netherlands: a bird's eye view. Pediatrics 1990; 86: 1044-7.
24. Fredriks AM, van Buuren S, Burgmeijer RJ, Meulmeester JF, Beuker RJ, Brugman E, et al., Continuing positive secular growth change in The Netherlands 1955-1997. Pediatr Res 2000; 47: 316-23.
25. Talma HY, Bakker B, Hirasing RA, Van Buuren S,. Handleiding bij het meten en wegen van kinderen en het invullen van groeidiagrammen. Leiden: TNO Quality of Life, 2010.
26. Laurent de Angulo MS, Brouwers-deJong EA, Bulk A,. Ontwikkelingsonderzoek in de jeugdgezondheidszorg: het van Wiechenonderzoek: de Baecke-Fassaert motoriektest, 4th edn. Assen, the Netherlands: Van Gorcum, 2008.
27. Jacobusse G, van Buuren S, Verkerk PH,. An interval scale for development of children aged 0-2 years. Stat Med 2006; 25: 2272-83.
28. ® during pregnancy and delivery outcome: a Swedish register study. BJOG 2012; 119: 1583-90.
29. Oppermann M, Fritzsche J, Weber-Schoendorfer C, Keller-Stanislawski B, Allignol A, Meister R, et al., A (H1N1) v2009: a controlled observational prospective cohort study on vaccine safety in pregnancy. Vaccine 2012; 30: 4445-52.
30. PRN. [ www.perinatreg.nl/uploads/150/136/Jaarboek-Zorg-in-Nederland-2009-Tabellen.pdf ]. Accessed 18 December 2013.
31. Engelberts AC, Koerts B, Waelkens JJ, Wit JM, Burger BJ,. Measuring the length of newborn infants. Ned Tijdschr Geneeskd 2005; 149: 632-6.
32. Villar J, Belizan JM,. The timing factor in the pathophysiology of the intrauterine growth retardation syndrome. Obstet Gynecol Surv 1982; 37: 499-506.
33. Symington A, Pinelli J,. Developmental care for promoting development and preventing morbidity in preterm infants. Cochrane Database Syst Rev 2006: CD001814.
34. Santo CC, Goncalves MT, Piccolo MM, Lima S, Rosa GJ, Paulin E, et al., Physical therapy performance in respiratory and motor involvement during postoperative in children submitted to abdominal surgeries. Acta Med Port 2011; 24: 1013-8.
35. Dereymaeker AM, Fryns JP, Haegeman J, Deroover J, Van den Berghe H,. A genetic-diagnostic survey in an institutionalized population of 158 mentally retarded patients. The Viaene experience. Clin Genet 1988; 34: 126-34.
36. Fryns JP, Kleczkowska A, Dereymaeker A, Hoefnagels M, Heremans G, Marien J, et al., A genetic-diagnostic survey in an institutionalized population of 173 severely mentally retarded patients. Clin Genet 1986; 30: 315-23.
37. Meador KJ, Baker GA, Browning N, Clayton-Smith J, Combs-Cantrell DT, Cohen M, et al., Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med 2009; 360: 1597-605.
38. Samren EB, van Duijn CM, Koch S, Hiilesmaa VK, Klepel H, Bardy AH, et al., Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy. Epilepsia 1997; 38: 981-90.
39. Prins SA, von Lindern JS, van Dijk S, Versteegh FG,. Motor development of premature infants born between 32 and 34 weeks. Int J Pediatr 2010; 2010: pii 462048.